Cargando…

Gas Vesicle Nanoparticles for Antigen Display

Microorganisms like the halophilic archaeon Halobacterium sp. NRC-1 produce gas-filled buoyant organelles, which are easily purified as protein nanoparticles (called gas vesicles or GVNPs). GVNPs are non-toxic, exceptionally stable, bioengineerable, and self-adjuvanting. A large gene cluster encodin...

Descripción completa

Detalles Bibliográficos
Autores principales: DasSarma, Shiladitya, DasSarma, Priya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586473/
https://www.ncbi.nlm.nih.gov/pubmed/26350601
http://dx.doi.org/10.3390/vaccines3030686
_version_ 1782392365519994880
author DasSarma, Shiladitya
DasSarma, Priya
author_facet DasSarma, Shiladitya
DasSarma, Priya
author_sort DasSarma, Shiladitya
collection PubMed
description Microorganisms like the halophilic archaeon Halobacterium sp. NRC-1 produce gas-filled buoyant organelles, which are easily purified as protein nanoparticles (called gas vesicles or GVNPs). GVNPs are non-toxic, exceptionally stable, bioengineerable, and self-adjuvanting. A large gene cluster encoding more than a dozen proteins has been implicated in their biogenesis. One protein, GvpC, found on the exterior surface of the nanoparticles, can accommodate insertions near the C-terminal region and results in GVNPs displaying the inserted sequences on the surface of the nanoparticles. Here, we review the current state of knowledge on GVNP structure and biogenesis as well as available studies on immunogenicity of pathogenic viral, bacterial, and eukaryotic proteins and peptides displayed on the nanoparticles. Recent improvements in genetic tools for bioengineering of GVNPs are discussed, along with future opportunities and challenges for development of vaccines and other applications.
format Online
Article
Text
id pubmed-4586473
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-45864732015-10-06 Gas Vesicle Nanoparticles for Antigen Display DasSarma, Shiladitya DasSarma, Priya Vaccines (Basel) Review Microorganisms like the halophilic archaeon Halobacterium sp. NRC-1 produce gas-filled buoyant organelles, which are easily purified as protein nanoparticles (called gas vesicles or GVNPs). GVNPs are non-toxic, exceptionally stable, bioengineerable, and self-adjuvanting. A large gene cluster encoding more than a dozen proteins has been implicated in their biogenesis. One protein, GvpC, found on the exterior surface of the nanoparticles, can accommodate insertions near the C-terminal region and results in GVNPs displaying the inserted sequences on the surface of the nanoparticles. Here, we review the current state of knowledge on GVNP structure and biogenesis as well as available studies on immunogenicity of pathogenic viral, bacterial, and eukaryotic proteins and peptides displayed on the nanoparticles. Recent improvements in genetic tools for bioengineering of GVNPs are discussed, along with future opportunities and challenges for development of vaccines and other applications. MDPI 2015-09-07 /pmc/articles/PMC4586473/ /pubmed/26350601 http://dx.doi.org/10.3390/vaccines3030686 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
DasSarma, Shiladitya
DasSarma, Priya
Gas Vesicle Nanoparticles for Antigen Display
title Gas Vesicle Nanoparticles for Antigen Display
title_full Gas Vesicle Nanoparticles for Antigen Display
title_fullStr Gas Vesicle Nanoparticles for Antigen Display
title_full_unstemmed Gas Vesicle Nanoparticles for Antigen Display
title_short Gas Vesicle Nanoparticles for Antigen Display
title_sort gas vesicle nanoparticles for antigen display
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586473/
https://www.ncbi.nlm.nih.gov/pubmed/26350601
http://dx.doi.org/10.3390/vaccines3030686
work_keys_str_mv AT dassarmashiladitya gasvesiclenanoparticlesforantigendisplay
AT dassarmapriya gasvesiclenanoparticlesforantigendisplay